FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Dacarbazine Injection
Status: Currently in Shortage
»Date first posted: 10/20/2021
»Therapeutic Categories: Oncology

Expand all

Fresenius Kabi USA, LLC (Reverified 09/04/2024)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 63323-127-10)	Available	Check wholesalers for inventory
Injection, 10 mg/1 mL (NDC 63323-128-20)	Available	Check wholesalers for inventory

Hikma Pharmaceuticals USA, Inc. (Revised 09/16/2024)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 200 mg per Vial (NDC 0143-9245-10)	Available	Currently available. Additional product will be made available as it is released.	Demand increase for the drug

Meitheal Pharmaceuticals, Inc. (New 07/22/2024)

Company Contact Information:
844-824-8426

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 200 mg/20 mL (NDC 71288-174-21)	Available	New launch